Replies to post #242582 on Biotech Values

[Biowatch]

Ouch. If you sell too many assets, you are left with nothing.

Asking to be taken over may at least provide some golden parachutes.

[vinmantoo]

CBIO—With traditional financing unavailable, some small biotechs are resorting to asset sales:

That brings back bad memories of GTCB.

[RNsidersbuying]

CBIO - today announced that it has signed a definitive asset purchase and sale agreement with Vertex Pharmaceuticals Incorporated under which Vertex has acquired Catalyst’s portfolio of protease medicines that regulate complement, including CB 2782-PEG, for $60 million in cash.

Why pay $60M cash for a corporation's asset when the entire market-cap of said corporation is less than $15M??? Kinda sure a valid business contract requires legitimate compensation from both parties!

https://docoh.com/filing/1124105/0001564590-22-018775/CBIO-10Q-2022Q1

[DewDiligence]

CBIO to liquidate and distribute cash to shareholders:

https://www.sec.gov/Archives/edgar/data/0001124105/000119312522184509/d205044ddefa14a.htm